Results 311 to 320 of about 838,425 (399)
Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis
What's New? Leptomeningeal disease is a highly palliative condition of tumor cell seeding that can cause symptomatic hydrocephalus. This multi‐center retrospective study of patients with leptomeningeal disease‐associated hydrocephalus compared the placement of ventriculoperitoneal shunts and Rickham reservoirs for cerebrospinal fluid drainage.
Obada T. Alhalabi+19 more
wiley +1 more source
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. [PDF]
Park YH+12 more
europepmc +1 more source
What's New? In selected patients with stage IV gastric cancer, radical surgery after conversion therapy may increase survival benefit; however, there is currently no standard protocol for conversion therapy. This prospective, single‐arm, single‐center, phase 2 study evaluated the feasibility of adding immunotherapy to a conversion treatment regimen to ...
Yong Liu+17 more
wiley +1 more source
Penehyclidine combined with antiemetics for preventing postoperative nausea and vomiting: A meta-analysis of randomized control trials and trial sequential analysis. [PDF]
Zhang H, Zheng J, Zhang L, Du L.
europepmc +1 more source
What's New? Omega‐3 docosahexaenoic acid (DHA) has shown pleiotropic anti‐cancer effects both in vitro and in animal models. However, clinical evidence of DHA efficacy is limited. This randomized, double‐blind, placebo‐controlled trial tested the efficacy of supplementation with DHA 4.4 g/day during 18 weeks of breast cancer neoadjuvant chemotherapy ...
Jaqueline Munhoz+16 more
wiley +1 more source
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]
Dhabhar B+10 more
europepmc +1 more source
What's New? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters+12 more
wiley +1 more source
What's New? The Quality of Life Questionnaire Core 30 (QLQ‐C30) is useful for assessing patient perspectives on the impact of cancer treatments on quality of life. However, thresholds to determine when patients are experiencing functional or symptomatic burdens remain under explored.
Bradley D. Menz+16 more
wiley +1 more source